Aardvark Therapeutics to Present at Upcoming Investor Conferences in September

SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, announced that it will present at the following conferences during September: Cantor Fitzgerald Global Healthcare Conference 2025 in New YorkPresentation: Wednesday, September 3 at 11:30 a.m. ET Morgan Stanley 23rd Annual Global He ...